{"id":"W2042846576","doi":"10.1097/jto.0b013e318168c815","title":"Second-Line Treatment of Advanced Non-small Cell Lung Cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Docetaxel; Pemetrexed; Erlotinib; Gefitinib; Chemotherapy; Oncology; Lung cancer; Internal medicine; Performance status; Cancer; Intensive care medicine; Epidermal growth factor receptor; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000758752,0.0001330898,0.0006255081,0.0001570707,0.00005344896,0.000001812941,0.00006249623,0.0000953816,0.0004805805],"category_scores_gemma":[0.00001143794,0.00009089614,0.0002075205,0.0001287458,0.00005821501,0.00006608715,0.000009800418,0.0001175549,0.00000416202],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008292633,"about_ca_system_score_gemma":0.001461886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003684195,"about_ca_topic_score_gemma":0.00006218062,"domain_scores_codex":[0.9990242,0.00003947585,0.0005085451,0.0001144814,0.0001384621,0.000174837],"domain_scores_gemma":[0.9987217,0.00007621571,0.0005846586,0.0001442851,0.0003157338,0.0001573819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.009317824,0.01300989,0.1524763,0.0009929157,0.004153617,0.006484267,0.02005639,0.002709481,0.1062462,0.00002028792,0.01137228,0.6731605],"study_design_scores_gemma":[0.03055368,0.05370718,0.1973736,0.000807805,0.009640064,0.007240835,0.002489556,0.0005588374,0.3291052,0.00009510492,0.3678539,0.0005742321],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839005,0.006331941,0.0001893019,0.001215264,0.0006367459,0.0003078806,0.00002208837,0.000006240485,0.007389981],"genre_scores_gemma":[0.9804613,0.003091739,0.008069729,0.0002175413,0.0003905546,0.0000232268,0.000006477821,0.0000183812,0.007721044],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6725863,"threshold_uncertainty_score":0.5262019,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02478428704914597,"score_gpt":0.4360008639625567,"score_spread":0.4112165769134107,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}